3
Announcements
Trials
Browse
Landscape
Status
Recruiting
747
Active not recruiting
461
Completed
285
Not yet recruiting
191
Terminated
127
Enrolling by invitation
15
Suspended
10
Withdrawn
8
Available
7
No longer available
4
Approved for marketing
2
Temporarily not available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
KRAS G12V Mutant Advanced Epithelial Cancers
1
Hematologic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
telisotuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Temporarily not available
×
Carcinoma, Non-Small-Cell Lung
×
1 year
×
Clear all
NCT04830202
2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available